Stocks News

LAST PRICE
60.5300
TODAY'S CHANGE (%)
Trending Up1.4700 (2.4890%)

Bid / Lots
60.4900/ 8
Ask / Lots
60.6200/ 1
Open / Previous Close
60.4200 / 59.0600
Day Range
Low 59.2900
High 62.5800
52 Week Range
Low 20.4000
High 62.5800
Volume
632,288
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 5, 2024
- Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition, from 9:05AM ET on Tuesday Nov 05, 2024 by Dow Jones
  9:05AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: AGIO
  
  whether as a result of new information, future events or otherwise, except as required by law.
  
  Contacts:
  
  Investor Contact
  
  Chris Taylor, VP, Investor Relations and Corporate Communications
Nov 1, 2024
- DJ Agios Pharmaceuticals Price Target Maintained With a $55.00/Share by RBC Capital, from 12:43PM ET on Friday Nov 01, 2024 by Dow Jones
  12:43PM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: AGIO
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/AGIO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 01, 2024 12:43 ET (16:43 GMT)
- DJ Agios Pharmaceuticals Is Maintained at Sector Outperform by Scotiabank, from 10:30AM ET on Friday Nov 01, 2024 by Dow Jones
  10:30AM ET on Friday Nov 01, 2024 by Dow Jones
  Companies Mentioned: AGIO
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/AGIO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 01, 2024 10:30 ET (14:30 GMT)
Oct 31, 2024
- Agios Pharmaceuticals Shares Fall After Q3 Revenue Miss, from 10:34AM ET on Thursday Oct 31, 2024 by MT Newswires
  10:34AM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: AGIO
  10:34 AM EDT, 10/31/2024 (MT Newswires) -- Agios Pharmaceuticals (AGIO) shares fell 2.7% in recent Thursday trading after the company's Q3 revenue fell below market expectations. The biopharmaceutical company reported Q3 net income Thursday of $16.2...
- -- Earnings Flash (AGIO) AGIOS PHARMACEUTICALS Reports Q3 Revenue $9.0M, from 6:30AM ET on Thursday Oct 31, 2024 by MT Newswires
  6:30AM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: AGIO
  06:30 AM EDT, 10/31/2024 (MT Newswires) -- ...

Nov 8, 2024
- DJ MoonLake Immunotherap Price Target Maintained With a $100.00/Share by HC Wainwright & Co., from 2:29PM ET on Friday Nov 08, 2024 by Dow Jones
  2:29PM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: MLTX
- DJ Edgewise Therapeutics Is Maintained at Outperform by Wedbush, from 10:36AM ET on Friday Nov 08, 2024 by Dow Jones
  10:36AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: EWTX
- RBC Capital Adjusts Edgewise Therapeutics Price Target to $44 From $42, Maintains Outperform, Speculative Risk Rating, from 9:57AM ET on Friday Nov 08, 2024 by MT Newswires
  9:57AM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: EWTX
Nov 7, 2024
- -- Earnings Flash (IOVA) IOVANCE BIOTHERAPEUTICS Posts Q3 Revenue $58.6M, from 4:09PM ET on Thursday Nov 07, 2024 by MT Newswires
  4:09PM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: IOVA
- *DJ Iovance Biotherapeutics 3Q Loss/Shr 28c >IOVA, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: IOVA
- Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: IOVA
- MoonLake Immunotherapeutics' Q3 Net Loss Widens, from 9:30AM ET on Thursday Nov 07, 2024 by MT Newswires
  9:30AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: MLTX
- Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: EWTX
- Press Release: Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: EWTX
- MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: MLTX

Agios Pharmaceuticals Inc
NASDAQ:AGIOUnited States

Search Criteria

Nov 5, 2024

Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition, from 9:05AM ET on Tuesday Nov 05, 2024 by Dow Jones

Nov 1, 2024

DJ Agios Pharmaceuticals Price Target Maintained With a $55.00/Share by RBC Capital, from 12:43PM ET on Friday Nov 01, 2024 by Dow Jones

DJ Agios Pharmaceuticals Is Maintained at Sector Outperform by Scotiabank, from 10:30AM ET on Friday Nov 01, 2024 by Dow Jones

Oct 31, 2024

Agios Pharmaceuticals Shares Fall After Q3 Revenue Miss, from 10:34AM ET on Thursday Oct 31, 2024 by MT Newswires

-- Earnings Flash (AGIO) AGIOS PHARMACEUTICALS Reports Q3 Revenue $9.0M, from 6:30AM ET on Thursday Oct 31, 2024 by MT Newswires

Peers Headlines

Nov 8, 2024

DJ MoonLake Immunotherap Price Target Maintained With a $100.00/Share by HC Wainwright & Co., from 2:29PM ET on Friday Nov 08, 2024 by Dow Jones

DJ Edgewise Therapeutics Is Maintained at Outperform by Wedbush, from 10:36AM ET on Friday Nov 08, 2024 by Dow Jones

RBC Capital Adjusts Edgewise Therapeutics Price Target to $44 From $42, Maintains Outperform, Speculative Risk Rating, from 9:57AM ET on Friday Nov 08, 2024 by MT Newswires

Nov 7, 2024

-- Earnings Flash (IOVA) IOVANCE BIOTHERAPEUTICS Posts Q3 Revenue $58.6M, from 4:09PM ET on Thursday Nov 07, 2024 by MT Newswires

*DJ Iovance Biotherapeutics 3Q Loss/Shr 28c >IOVA, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones

MoonLake Immunotherapeutics' Q3 Net Loss Widens, from 9:30AM ET on Thursday Nov 07, 2024 by MT Newswires

Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones

Press Release: Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones